全球微型RNA市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年， 微型RNA市场规模将从 2025 年的 28 亿美元成长至 292.3 亿美元，2026 年至 2034 年的复合年增长率为 29.76%。

随着分子生物学和基因诊断研究的不断深入，全球微型RNA市场正蓬勃发展。 microRNA在基因调控和疾病进展中发挥着至关重要的作用，并作为癌症和其他慢性疾病的重要生物标记而备受关注。基因组研究投入的增加正显着推动市场成长。

关键成长要素包括RNA定序技术的进步和个人化医疗方法的日益普及。製药公司正在探索基于微型RNA的疗法，并加强其研发管线。政府资助和与学术机构的合作也促进了市场成长。

展望未来，RNA递送系统和诊断平台的技术进步可望进一步拓展其临床应用。将微型RNA研究融入精准医疗策略，可望开闢新的治疗途径，并支持市场的长期发展。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球微型RNA市场：依服务分类

• 市场分析、洞察与预测
• 检体
• 服务类型

第五章 全球微型RNA市场：依产品划分

• 市场分析、洞察与预测
• 装置
• 消耗品

第六章 全球微型RNA市场：依应用划分

• 市场分析、洞察与预测
• 癌症
• 感染疾病
• 免疫疾病
• 心血管疾病
• 神经系统疾病
• 其他的

第七章：全球微型RNA市场：依最终用途划分

• 市场分析、洞察与预测
• 生物技术和製药公司
• 学术机构与政府研究机构
• 其他的

第八章 全球微型RNA市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Horizon Discovery Ltd
  • Synlogic
  • Qiagen
  • GeneCopoeia Inc
  • New England Biolabs
  • Quantabio
  • NanoString
  • BioGenex
  • SeqMatic LLC
  • Miltenyi Biotec
  • Sistemic Scotland Limited
  • Biodynamics Laboratory Inc
  • OriGene Tec

The MicroRNA Market size is expected to reach USD 29.23 Billion in 2034 from USD 2.80 Billion (2025) growing at a CAGR of 29.76% during 2026-2034.

The global microRNA market is gaining momentum due to growing research in molecular biology and genetic diagnostics. MicroRNAs play a crucial role in gene regulation and disease progression, making them valuable biomarkers for cancer and other chronic conditions. Rising investments in genomics research are significantly supporting market expansion.

Key growth drivers include advancements in RNA sequencing technologies and increasing adoption of personalized medicine approaches. Pharmaceutical companies are exploring microRNA-based therapeutics, strengthening the research pipeline. Government funding and academic collaborations further contribute to market growth.

Looking ahead, technological improvements in RNA delivery systems and diagnostic platforms are expected to enhance clinical applications. The integration of microRNA research into precision medicine strategies may open new treatment opportunities, supporting long-term market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Services

• Specimen
• Service Type

By Products

• Instruments
• Consumables

By Application

• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

By End-Use

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

COMPANIES PROFILED

• Merck KGaA, Thermo Fisher Scientific Inc, Horizon Discovery Ltd, Synlogic, Qiagen, GeneCopoeia Inc, New England Biolabs, Quantabio, NanoString, BioGenex, SeqMatic LLC, Miltenyi Biotec, Sistemic Scotland Limited, Biodynamics Laboratory Inc, OriGene Tec
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MICRORNA MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Specimen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Service Type Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MICRORNA MARKET: BY PRODUCTS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Products
• 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MICRORNA MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Immunological Disorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Neurological Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MICRORNA MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Government Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MICRORNA MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Services
  • 8.2.2 By Products
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Services
  • 8.3.2 By Products
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Services
  • 8.4.2 By Products
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Services
  • 8.5.2 By Products
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Services
  • 8.6.2 By Products
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MICRORNA INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Merck KGaA
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 Horizon Discovery Ltd
  • 10.2.4 Synlogic
  • 10.2.5 Qiagen
  • 10.2.6 GeneCopoeia Inc
  • 10.2.7 New England Biolabs
  • 10.2.8 Quantabio
  • 10.2.9 NanoString
  • 10.2.10 BioGenex
  • 10.2.11 SeqMatic LLC
  • 10.2.12 Miltenyi Biotec
  • 10.2.13 Sistemic Scotland Limited
  • 10.2.14 Biodynamics Laboratory Inc
  • 10.2.15 OriGene Tec